# Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors

> **NCT01628640** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 17 (actual)

## Conditions studied

- Advanced Malignant Solid Neoplasm
- Hepatocellular Carcinoma

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Pharmacological Study
- **BIOLOGICAL:** Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta

## Key facts

- **NCT ID:** NCT01628640
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-03
- **Primary completion:** 2019-04-19
- **Final completion:** 2019-04-19
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01628640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01628640, "Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01628640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*